CD8A and neoplasm: Although CpG treatment did not increase the frequency of T-bet+ in CD8+ T cells, the T-bet levels were increased in tumor-reactive CD8+ T cells by CpG (Figure 2C), suggesting that CpG signals increase the expression of T-bet at a single cell level that may contribute to PD-1 down-regulation.